Antipsychotic Drugs Market is anticipated to growing at a CAGR of 4.3% by 2022

Market Highlights

Market research future published a half-cooked research report on global Antipsychotic Drugs market. The global Antipsychotic Drugs market is expected to grow at a CAGR of ~4.3% during the period 2016 to 2022.

Anti-psychotics are drugs used in the treatment of psychosis which are a group of disorders characterized by serious distortion of thought, behavior, recognition of reality and perception, delusions and hallucinations.

The market for psychotics represents a huge potential as can be seen from the following estimates by World Health Organization (WHO)
• Depression affects an estimated 300 million people in the world.
• Bipolar affective disorder takes a toll on about 60 million people worldwide.
• Schizophrenia, a severe mental disorder, affects about 21 million people worldwide.
• Dementia has a prevalence in about 47.5 million people worldwide
• One fourth of people are affected by mental or neurological disorders at some point in their lives.

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2784

Major Key Players
• Eli Lilly & Co.,
• Bristol-Myers Squibb,
• AstraZeneca,
• Pfizer Inc.,
• GlaxoSmithKline Plc.,
• Johnson & Johnson

Thus the current number of untapped patients is of an order of around 450 million. Other market drivers are growing awareness and focus on mental illness, inclusion of more conditions such as learning disability in the mental disorders segment, rise of geriatrics population and mental hospitals etc.

The market constraints are social stigma and discrimination, poor efficacy and efficiency of anti-psychotic drugs, serious side effects such as habit forming potential etc. Patent expiry is also constraining the market as a number of established brands such as, Zyprexa, Seroquel, Risperdal lost patents. The drug development pipeline represents another miserable situation. The development pipeline is poor with a few if any novel acting drugs. The market represents numerous drugs with same mechanism of action and similar therapeutic profile which has hampered the market.
Test the market data and market information presented through more than 60 market data tables and figures spread over 84 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Antipsychotic Drugs Market Research Report - Forecast to 2022”.

Access Report Details @ https://www.marketresearchfuture.com/reports/antipsychotic-drugs-market

Global Antipsychotic Drugs Market:
The global antipsychotic drugs market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The global antipsychotic drugs market is expected to grow with CAGR of ~4.3% during the forecast period. The market for anti-psychotics favors companies with strong research skills and pipelines. Contract research companies also will find high opportunity in the antipsychotic drugs market. The market is hungry for a novel acting drug molecule which will result in extremely fast market uptake at a minimum of marketing cost.

Regional Analysis:
Depending on geographic region, antipsychotic drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for Antipsychotic Drugs as there is a consistent technological advancement which has helped in early diagnosis of the osteoporosis which has projected high growth of antipsychotic drugs market in this region. Europe is the second-largest market for antipsychotic drugs. Asia pacific region is expected to be fastest growing region in antipsychotic drugs market due to increasing investments in the healthcare sector and increasing acceptance of these devices by the healthcare providers.

Segmentation:
Global antipsychotic drugs market has been segmented on the basis of therapeutic applications, which comprises schizophrenia, bipolar disorder, depression, dementia and others. On the basis of generations; market is segmented into first, second and third.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/2784

List of Tables
TABLE 1 GLOBAL ANTI-PSYCHOTIC DRUGS MARKET, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL ANTI-PSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATION, 2013-2022
TABLE 3 GLOBAL ANTI-PSYCHOTIC DRUGS MARKET, BY GENERATION, 2013-2022
Continued…

List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL ANTI-PSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATION
Continued….

Browse Related Statistical Reports

Canada Clinical Laboratory Test Market is projected to grow at a CAGR of 6.3% and is expected to reach US$ 12,408.3 million by 2022. In Canada Clinical Laboratory Test Market, The region is expected to show lucrative growth opportunities for market players entering the Canadian market.

https://www.marketresearchfuture.com/statistical-reports/canada-clinical-laboratory-test-market-3105

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.